BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37940765)

  • 1. The value of Korean, American, and Chinese ultrasound risk stratification systems combined with BRAF(V600E) mutation for detecting papillary thyroid carcinoma in cytologically indeterminate thyroid nodules.
    Lin Y; Cheng Y; Zhang Y; Ren X; Li J; Shi H; Li Y; Luo Y; Wang H
    Endocrine; 2024 May; 84(2):549-559. PubMed ID: 37940765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of FNAC combined with BRAF
    Fu J; Yin X; Wang X; Xiao S; Wu X; Duan C; Yu W; Zhang G
    Front Endocrinol (Lausanne); 2024; 15():1366724. PubMed ID: 38818506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Efficacy of Ultrasound, Cytology, and BRAF
    Du J; Han R; Chen C; Ma X; Shen Y; Chen J; Li F
    Front Oncol; 2021; 11():746776. PubMed ID: 35047385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis of diffuse sclerotic thyroid papillary carcinoma and Hashimoto's thyroiditis using fine-needle aspiration cytology, BRAF
    Wang X; Xu F; Gao J; Agyekum EA; Sun H; Zhang G; Li X; Xiang H; Hu S; Qian X
    J Clin Ultrasound; 2022 Sep; 50(7):942-950. PubMed ID: 35779272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules.
    Beiša A; Kvietkauskas M; Beiša V; Stoškus M; Ostanevičiūtė E; Jasiūnas E; Griškevičius L; Šeinin D; Šileikytė A; Strupas K
    Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):247-254. PubMed ID: 29566402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of BRAF V600E mutation detection of fine-needle aspiration biopsy on diagnosis and treatment guidance of papillary thyroid carcinoma.
    Qi W; Shi C; Zhang P; Feng L; Wang J; Chen D
    Pathol Res Pract; 2020 Aug; 216(8):153037. PubMed ID: 32703500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of
    Chen X; Zhou Q; Wang F; Zhang F; Du H; Zhang Q; Wu W; Gong X
    AJNR Am J Neuroradiol; 2018 Dec; 39(12):2360-2365. PubMed ID: 30498021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An economically efficient strategy for diagnosing atypia of undetermined significance or follicular lesion of undetermined significance thyroid nodules with ultrasound-based risk stratification systems and
    Ma X; Huang Y; Shen R; Cui Y; Kang Y; Yu J; Cui K
    Quant Imaging Med Surg; 2024 Jan; 14(1):920-931. PubMed ID: 38223096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of S-Detect and thyroid imaging reporting and data system classifications in the diagnosis of cytologically indeterminate thyroid nodules.
    Zhou L; Zheng LL; Zhang CJ; Wei HF; Xu LL; Zhang MR; Li Q; He GF; Ghamor-Amegavi EP; Li SY
    Front Endocrinol (Lausanne); 2023; 14():1098031. PubMed ID: 36761203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High BRAFV600E mutation frequency in Chinese patients with papillary thyroid carcinoma increases diagnostic efficacy in cytologically indeterminate thyroid nodules.
    Li XJ; Mao XD; Chen GF; Wang QF; Chu XQ; Hu X; Ding WB; Zeng Z; Wang JH; Xu SH; Liu C
    Medicine (Baltimore); 2019 Jul; 98(28):e16343. PubMed ID: 31305422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF V600E as an accurate marker to complement fine needle aspiration (FNA) cytology in the guidance of thyroid surgery in the Chinese population: evidence from over 1000 consecutive FNAs with follow-up.
    Zhao Q; Wang Y; Ye Q; Wang P; Rao J
    Jpn J Clin Oncol; 2021 Apr; 51(4):590-594. PubMed ID: 33237284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic values of BRAF(V600E) mutation analysis and Bethesda system for reporting thyroid cytopathology in thyroid nodules with TIRADS 4 and 5].
    Han Y; Zhao BW; Li SY; Lyu JG; Shou JD; Xu HS; Lou HY; Xu LL; Gao L; Xu SX; Zhu J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 52(9):686-691. PubMed ID: 28910894
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
    Chung KW; Yang SK; Lee GK; Kim EY; Kwon S; Lee SH; Park DJ; Lee HS; Cho BY; Lee ES; Kim SW
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):660-6. PubMed ID: 17054470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of high-frequency ultrasound combined with fine needle aspiration cytology and BRAF gene for papillary thyroid microcarcinoma.
    Li C; Zhao X; Zhao J; Zhao J; An L; Wu G
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):187-191. PubMed ID: 38650135
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Zhu Y; Wu H; Huang B; Shen X; Cai G; Gu X
    Gland Surg; 2020 Oct; 9(5):1674-1684. PubMed ID: 33224845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.
    Paek SH; Kim BS; Kang KH; Kim HS
    World J Surg Oncol; 2017 Nov; 15(1):202. PubMed ID: 29132392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
    Rossi M; Buratto M; Bruni S; Filieri C; Tagliati F; Trasforini G; Rossi R; Beccati MD; Degli Uberti EC; Zatelli MC
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.
    Lee ST; Kim SW; Ki CS; Jang JH; Shin JH; Oh YL; Kim JW; Chung JH
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2299-306. PubMed ID: 22500044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF
    Chen H; Song A; Wang Y; He Y; Tong J; Di J; Li C; Zhou Z; Cai X; Zhong D; Da J
    Cancer Med; 2022 Jan; 11(1):40-49. PubMed ID: 34851044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical role of BRAF V600E mutation testing in thyroid nodules].
    Wan H; Zhang B; Wang Y; Xiao T; Guo H; Liu W; Yan D; Xu Z; Tang P
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jun; 49(6):468-72. PubMed ID: 25241863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.